Alliancebernstein L.P. Prometheus Biosciences, Inc. Transaction History

Alliancebernstein L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$103.46 - $126.29 $1.1 Million - $1.34 Million	10,600 Added 34.75%	41,100 $4.41 Million
Q4 2022 Feb 14, 2023	SELL	$36.06 - $117.21 $21,636 - $70,326	-600 Reduced 1.93%	30,500 $3.36 Million
Q2 2022 Aug 15, 2022	BUY	$22.39 - $38.94 $20,151 - $35,046	900 Added 2.98%	31,100 $878,000
Q1 2022 May 13, 2022	BUY	$30.13 - $50.0 $909,926 - $1.51 Million	30,200 New	30,200 $1.14 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.